Compound details
Neonaucleoside C
| Compound ID | CDAMM02234 |
|---|---|
| Common name | Neonaucleoside C | IUPAC name | 1-[[3-ethenyl-5-methoxycarbonyl-2-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3,4-dihydro-2H-pyran-4-yl]methyl]-4-[5-ethenyl-1-oxo-6-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4,4a,5,6-tetrahydro-3H-pyrano[3,4-c]pyran-3-yl]-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole-3-carboxylic acid |
| Molecular formula | C44H54N2O20 |
| Retention time | 0.45 |
|---|---|
| Adduct | [M+H]+ |
| Actual mz | 931.334 | Theoretical mz | 931.334 |
| Error | 0.08 |
| Ionizaton mode | Positive |
| Instrument type | LC-MS/MS-QTOF, spectrum predicted by MS-DIAL v4.9 integrated with MS-FINDER 3.60 |
| Score | 6.0515 |
| Inchi key | APXDLYAWLHQGTH-RUDXOEORNA-N |
|---|---|
| Smiles | O=C(O)C1NC(C=2NC=3C=CC=CC3C2C1C4OC(=O)C5=COC(OC6OC(CO)C(O)C(O)C6O)C(C=C)C5C4)CC7C(=COC(OC8OC(CO)C(O)C(O)C8O)C7C=C)C(=O)OC |
| Superclass | Lipids and lipid-like molecules |
| Class | Prenol lipids |
| TTD_ID | Disease_ID | Disease name | ICD_11 | Uniprot ID | Gene names |
|---|---|---|---|---|---|
| T20761 | DI0095 | Colorectal cancer | [ICD-11: 2B91] | P15692 | VEGFA |
| T20761 | DI0365 | Retinopathy | [ICD-11: 9B71] | P15692 | VEGFA |
| T20761 | DI0430 | Vascular system developmental anomaly | [ICD-11: LA90] | P15692 | VEGFA |
| T18639 | DI0081 | Chronic arterial occlusive disease | [ICD-11: BD4Z] | P05230 | FGF1 |
| T18639 | DI0102 | Coronary atherosclerosis | [ICD-11: BA52] | P05230 | FGF1 |
| T31621 | DI0005 | Acne vulgaris | [ICD-11: ED80] | P09038 | FGF2 |
| T61698 | DI0275 | Multiple sclerosis | [ICD-11: 8A40] | P60568 | IL2 |
| T61698 | DI0361 | Renal cell carcinoma | [ICD-11: 2C90] | P60568 | IL2 |